http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013133731-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-42
filingDate 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2013133731-A
titleOfInvention BONE SUBSTITUTE MATERIAL
abstract 1. A porous biphasic calcium phosphate / hydroxyapatite (FC / HAP) material as a bone substitute, containing a sintered FC rod and at least one homogeneous and closed epitaxy grown nanocrystalline HAP layer deposited on top of the sintered FC rod, while epitaxy grown nanocrystals have such the same size and structure as the human bone mineral, i.e. a length of 30-46 nm, and a width of 14-22 nm, which is impregnated with collagen fibers in a weight ratio of these collagen fibers to the specified porous biphasic calcium phosphate / hydroxyapatite (FC / HAP) material as a bone substitute, at least 2% .2. The porous FC / HAP bone substitute material according to claim 1, wherein the weight ratio of said collagen fibers to said porous biphasic calcium phosphate / hydroxyapatite (FC / HAP) material as a bone substitute is at least 5% .3. The porous FC / HAP bone substitute material according to claim 1, wherein the weight ratio of said collagen fibers to said porous biphasic calcium phosphate / hydroxyapatite (FC / HAP) material as a bone substitute is at least 8% .4. The porous FC / HAP bone substitute material according to claim 1, wherein the weight ratio of said collagen fibers to said porous biphasic calcium phosphate / hydroxyapatite phosphate (FC / HAP) material as a bone substitute is from 8 to 25% .5. Porous FC / HAP bone substitute material in accordance with any of paragraphs. 1-4, where the collagen fibers are collagen fibers of type I, collagen type�
priorityDate 2010-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452135712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454118689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14781
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24456

Total number of triples: 26.